Glutaminase, which converts glutamine to glutamate, is involved in Warburg effect in cancer cells. Two human glutaminase genes have been identified, GLS (GLS1) and GLS2. Two alternative transcripts arise from each glutaminase gene: first, the kidney isoform (KGA) and glutaminase C (GAC) for GLS; and, second, the liver isoform (LGA) and glutaminase B (GAB) for GLS2. While GLS1 is considered as a cancer therapeutic target, the potential role of GLS2 in cancer remains unclear. Here, we discovered a series of alkyl benzoquinones that preferentially inhibit glutaminase B isoform (GAB, GLS2) rather than the kidney isoform of glutaminase (KGA, GLS1). We identified amino acid residues in an allosteric binding pocket responsible for the selectivity. Treatment with the alkyl benzoquinones decreased intracellular glutaminase activity and glutamate levels. GLS2 inhibition by either alkyl benzoquinones or GLS2 siRNA reduced carcinoma cell proliferation and anchorage-independent colony formation, and induced autophagy via AMPK mediated mTORC1 inhibition. Our findings demonstrate amino acid sequences for selective inhibition of glutaminase isozymes and validate GLS2 as a potential anti-cancer target.

No abstract

The first total synthesis of cytopiloyne 1, a novel bioactive polyacetylenic glucoside isolated from the extract of Bidens pilosa, is described. The structure of cytopiloyne was determined to be 2-β-D-glucopyranosyloxy-1-hydroxytrideca-5,7,9,11-tetrayne by using various spectroscopic methods, but the chirality of the polyyne moiety was unknown. Herein, the convergent synthesis of two diastereomers of cytopiloyne by starting from commercially available 4-(2-hydroxyethyl)-2,2-dimethyl-1,3-diozolane is described. The synthetic sequence involved two key steps: stereoselective glycosylation of the glucosyl trichloroacetimidate with 1-[(4-methoxybenzyl)oxy]hex-5-yn-2-ol to give the desired β-glycoside and the construction of the glucosyl tetrayne skeleton by using a palladium/silver-catalyzed cross-coupling reaction to form the alkyne-alkyne bond, the first such use of this reaction. Comparison between the observed and published characterization data showed the 2R isomer to be the natural product cytopiloyne.

The extraction behaviour of U(VI), Th(IV) and Nd(III) was investigated as a function of nitric acid concentration for diamide based extractants, namely, N,N,N′,N′-tetraoctyl-3-carbonylpentanediamide (TOCPDA) and 4-carbonyl-heptanedioic acid bis-dioctylamide (CHADA). In addition, the distribution ratio was also measured for Pu(IV) and Sr(II) with 1.1 M CHADA in n-dodecane. These extractants were synthesized by adopting simple acid, amine coupling reaction with DCC (dicyclohexylcarbodiimide) and DMAP (N,N′-dimethylaminopyridine) as the coupling agent. The newly synthesized extractants were characterized by FT-IR, NMR, Mass, CHNS and HPLC. The extraction results indicated that CHADA shown has better extraction behavior for U(VI) compared to TOCPDA. In addition, CHADA coated HPLC column was examined for the retention behaviour of U(VI), Th(IV), and Nd(III). Computation studies based on density functional theory (DFT) were carried out to understand the complexing behaviour of U(VI), Pu(IV) and Sr(II) with CHADMA and TMCPDA.

The First Total Synthesis of Cytopiloyne, an Antidiabetic Polyacetylenic Glucoside. -Both diastereomers are prepared and their structures are characterized. Comparison of the new data with those in the literature confirm that the (2R)-diastereomer (I) is the natural product. -(KUMAR, C. R.; TSAI, C.-H.; CHAO, Y.-S.; LEE*, J.-C.; Chem. Eur. J. 17 (2011) 31, 8696-8703, http://dx.

No abstract